CeriBell shares were higher after the medical technology company issued a tariff-related update about products sourced from China. The stock was up 33% to $14.85 on Friday, recovering from Thursday's ...

CeriBell, Inc. is a medical technology firm in the commercial phase, renowned for creating the CeriBell System, an innovative, portable electroencephalography (EEG) solution tailored for acute ...

Key Insights Institutions' substantial holdings in CeriBell implies that they have significant influence over the... CeriBell Inc (CBLL) reports a 41% revenue increase and strategic expansions ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

Ladenburg initiated coverage of Ceribell (CBLL) with a Buy rating and $32 price target The company has a first-mover advantage in scaling ...

Fintel reports that on April 4, 2025, Ladenburg Thalmann initiated coverage of CeriBell (NasdaqGS:CBLL) with a Buy ...

CeriBell (NASDAQ:CBLL – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports.

On Friday, William Blair reiterated its Outperform rating and $15.00 price target on Ceribell (NASDAQ:CBLL) shares, following the company’s recent update on the potential impact of rising China ...

Nuwellis (NASDAQ:NUWE – Get Free Report) and CeriBell (NASDAQ:CBLL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based ...

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include ...

SUNNYVALE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...